OVID THERAPEUTICS INC (OVID) Institutional Ownership Changes & 13F Activity
OVID THERAPEUTICS INC (OVID). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Braidwell Lp, Saturn V Capital Management Lp, Adar1 Capital Management, Llc, Stempoint Capital Lp, and Ally Bridge Group (Ny) Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +40,910 | — | 40,910 | $110.05K | Q2 2026 | Sep 09, 2026 |
| California State Teachers Retirement System | Buy | +2,109 | — | 2,109 | $5.67K | Q2 2026 | Aug 24, 2026 |
| Assenagon Asset Management S.A. | Sell | -210,198 | -92.3% | 17,544 | $47.19K | Q2 2026 | Aug 21, 2026 |
| Stonepine Capital Management, Llc | Sell | -18,700 | -46.8% | 21,300 | $57.30K | Q2 2026 | Aug 17, 2026 |
| Braidwell Lp | Buy | +5,919,464 | — | 5,919,464 | $15.92M | Q2 2026 | Aug 14, 2026 |
| Saturn V Capital Management Lp | Sell | -3,503,606 | -84.1% | 663,060 | $1.78M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +2,873,366 | +63.2% | 7,417,479 | $19.95M | Q2 2026 | Aug 14, 2026 |
| Stempoint Capital Lp | Buy | +2,417,283 | — | 2,417,283 | $6.50M | Q2 2026 | Aug 14, 2026 |
| Ally Bridge Group (Ny) Llc | Sell | -2,193,898 | -77.8% | 624,561 | $1.68M | Q2 2026 | Aug 14, 2026 |
| Eventide Asset Management, Llc | Buy | +1,895,330 | +19.1% | 11,812,241 | $31.77M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -1,876,994 | -96.4% | 70,600 | $189.91K | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -1,464,223 | -97.8% | 32,295 | $86.87K | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Buy | +1,186,003 | +21.4% | 6,719,076 | $18.07M | Q2 2026 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | Buy | +988,084 | — | 988,084 | $2.66M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Buy | +747,000 | — | 747,000 | $2.01M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +625,117 | +47.3% | 1,945,727 | $5.23M | Q2 2026 | Aug 14, 2026 |
| Ikarian Capital, Llc | Sell | -625,000 | -21.6% | 2,269,704 | $6.11M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Sell | -424,491 | -33.8% | 832,378 | $2.24M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +372,042 | +516.7% | 444,042 | $1.19M | Q2 2026 | Aug 14, 2026 |
| Sphera Funds Management Ltd. | Sell | -269,828 | -16.6% | 1,353,000 | $3.64M | Q2 2026 | Aug 14, 2026 |
| Atom Investors Lp | Buy | +251,836 | — | 251,836 | $677.44K | Q2 2026 | Aug 14, 2026 |
| Sio Capital Management, Llc | Sell | -247,047 | -19.7% | 1,005,334 | $2.70M | Q2 2026 | Aug 14, 2026 |
| Ra Capital Management, L.P. | Sell | -213,032 | -2.0% | 10,500,968 | $28.25M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Sell | -190,155 | -20.5% | 737,758 | $1.98M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +179,845 | +117.7% | 332,692 | $894.94K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -179,034 | -90.4% | 18,937 | $50.94K | Q2 2026 | Aug 14, 2026 |
| Schonfeld Strategic Advisors Llc | Sell | -177,162 | -83.5% | 35,049 | $94.28K | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +174,900 | — | 174,900 | $470.48K | Q2 2026 | Aug 14, 2026 |
| Rafferty Asset Management, Llc | Buy | +136,774 | — | 136,774 | $367.92K | Q2 2026 | Aug 14, 2026 |
| Sei Investments Co | Sell | -132,239 | -40.2% | 196,685 | $529.08K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about OVID activity
Which institutional owners are buying OVID?
Institutional owners buying OVID include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in OVID activity?
"Buy" means an investor increased their reported position in OVID compared to the prior reporting period. This reflects growing exposure to OVID THERAPEUTICS INC (OVID) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in OVID increasing?
Institutional interest in OVID can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related OVID Institutional Insights
- OVID Overview
- OVID 13F Institutional Holders
- OVID Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- OVID Insider Trading & SEC Form 4 Activity
- OVID Articles
- Top Institutional Investor Stock Rankings